DALLAS GALLAGHER: Open Payments
NPI 1871262345 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$19,491 in 37 payments from 7 companies in 2025. Trend: 2023 $6,372 · 2024 $1,738 · 2025 $19,491
Speaker / faculty: $9,865Travel & lodging: $4,690Consulting: $2,835Food & beverage: $2,022Education: $79
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 8 | $7,421 |
| Ipsen Biopharmaceuticals, Inc | 10 | $6,277 |
| ABBVIE INC. | 13 | $3,897 |
| E.R. Squibb & Sons, L.L.C. | 2 | $1,335 |
| AstraZeneca Pharmaceuticals LP | 2 | $256 |
| IntrinsiQ Specialty Solutions, Inc. | 1 | $197 |
| Astellas Pharma US Inc | 1 | $109 |
Products named: Onivyde, CREON, IMJUDO, Vyloy.
Industry payments across CA — which companies pay providers there.
